Northeast Pharmaceutical Group Co Ltd (000597) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, Northeast Pharmaceutical Group Co Ltd (000597) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥274.09 Million ≈ $40.11 Million USD) by net assets (CN¥5.60 Billion ≈ $819.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Northeast Pharmaceutical Group Co Ltd (000597) defensive interval to measure how many days the company can operate on defensive assets alone.

Northeast Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Northeast Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Northeast Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Northeast Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Wuhan LinControl Automotive Electronics Co. Ltd. A SHG:688667	0.053x
Kayne Anderson BDC, Inc. NYSE:KBDC	0.037x
Inwido AB ST:INWI	-0.029x
Shijiazhuang Tonhe Electronics Technologies Co Ltd SHE:300491	0.075x
LightPath Technologies Inc NASDAQ:LPTH	-0.060x
Vats Liquor Chain Store Management Joint Stock Co Ltd SHE:300755	0.146x
Sonata Software Limited NSE:SONATSOFTW	0.021x
Beijing New Space Technology Co Ltd SHG:605178	0.001x

Annual Cash Flow Conversion Efficiency for Northeast Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Northeast Pharmaceutical Group Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Northeast Pharmaceutical Group Co Ltd (000597) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.67 Billion ≈ $829.59 Million	CN¥1.11 Billion ≈ $161.90 Million	0.195x	+43.25%
2024-12-31	CN¥5.57 Billion ≈ $815.01 Million	CN¥758.76 Million ≈ $111.03 Million	0.136x	+19.78%
2023-12-31	CN¥5.16 Billion ≈ $754.89 Million	CN¥586.75 Million ≈ $85.86 Million	0.114x	-51.64%
2022-12-31	CN¥4.71 Billion ≈ $689.70 Million	CN¥1.11 Billion ≈ $162.22 Million	0.235x	+35.17%
2021-12-31	CN¥4.29 Billion ≈ $627.80 Million	CN¥746.51 Million ≈ $109.24 Million	0.174x	+25.63%
2020-12-31	CN¥4.12 Billion ≈ $603.21 Million	CN¥570.92 Million ≈ $83.54 Million	0.138x	+53.89%
2019-12-31	CN¥3.92 Billion ≈ $573.30 Million	CN¥352.60 Million ≈ $51.60 Million	0.090x	+13.42%
2018-12-31	CN¥3.59 Billion ≈ $525.75 Million	CN¥285.09 Million ≈ $41.72 Million	0.079x	+167.13%
2017-12-31	CN¥2.55 Billion ≈ $372.85 Million	CN¥-301.20 Million ≈ $-44.07 Million	-0.118x	-174.83%
2016-12-31	CN¥2.43 Billion ≈ $356.17 Million	CN¥384.51 Million ≈ $56.27 Million	0.158x	+280.44%
2015-12-31	CN¥2.40 Billion ≈ $351.34 Million	CN¥99.70 Million ≈ $14.59 Million	0.042x	+144.00%
2014-12-31	CN¥2.76 Billion ≈ $404.05 Million	CN¥46.99 Million ≈ $6.88 Million	0.017x	+110.22%
2013-12-31	CN¥1.60 Billion ≈ $233.99 Million	CN¥-266.38 Million ≈ $-38.98 Million	-0.167x	-438.70%
2012-12-31	CN¥1.75 Billion ≈ $256.13 Million	CN¥86.09 Million ≈ $12.60 Million	0.049x	+136.74%
2011-12-31	CN¥1.74 Billion ≈ $255.03 Million	CN¥-233.32 Million ≈ $-34.14 Million	-0.134x	-208.03%
2010-12-31	CN¥2.07 Billion ≈ $302.24 Million	CN¥255.96 Million ≈ $37.46 Million	0.124x	-58.68%
2009-12-31	CN¥2.05 Billion ≈ $300.50 Million	CN¥615.91 Million ≈ $90.13 Million	0.300x	-33.40%
2008-12-31	CN¥1.57 Billion ≈ $230.40 Million	CN¥709.03 Million ≈ $103.75 Million	0.450x	+101.66%
2007-12-31	CN¥889.22 Million ≈ $130.12 Million	CN¥198.56 Million ≈ $29.06 Million	0.223x	+295.39%
2006-12-31	CN¥927.49 Million ≈ $135.72 Million	CN¥-106.00 Million ≈ $-15.51 Million	-0.114x	-192.34%
2005-12-31	CN¥900.07 Million ≈ $131.71 Million	CN¥111.40 Million ≈ $16.30 Million	0.124x	-48.16%
2004-12-31	CN¥884.02 Million ≈ $129.36 Million	CN¥211.06 Million ≈ $30.88 Million	0.239x	-9.70%
2003-12-31	CN¥870.26 Million ≈ $127.35 Million	CN¥230.08 Million ≈ $33.67 Million	0.264x	+46.67%
2002-12-31	CN¥873.28 Million ≈ $127.79 Million	CN¥157.41 Million ≈ $23.03 Million	0.180x	+101.95%
2001-12-31	CN¥883.36 Million ≈ $129.26 Million	CN¥78.84 Million ≈ $11.54 Million	0.089x	+123.72%
2000-12-31	CN¥905.53 Million ≈ $132.51 Million	CN¥36.13 Million ≈ $5.29 Million	0.040x	-36.48%
1999-12-31	CN¥869.73 Million ≈ $127.27 Million	CN¥54.62 Million ≈ $7.99 Million	0.063x	+926.23%
1998-12-31	CN¥999.14 Million ≈ $146.21 Million	CN¥-7.59 Million ≈ $-1.11 Million	-0.008x	--

About Northeast Pharmaceutical Group Co Ltd

SHE:000597 China Drug Manufacturers - Specialty & Generic

Market Cap

$916.75 Million

CN¥6.26 Billion CNY

Market Cap Rank

#9450 Global

#2454 in China

Share Price

CN¥4.39

Change (1 day)

-1.35%

52-Week Range

CN¥4.38 - CN¥6.49

All Time High

CN¥133.00